​

LeMaitre Vascular (LMAT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LMAT Stock Forecast

LeMaitre Vascular (LMAT) stock forecast, based on 20 Wall Street analysts, predicts a 12-month average price target of $101.50, with a high of $108.00 and a low of $95.00. This represents a -4.73% decline from the last price of $106.54.

$55 $66 $77 $88 $99 $110 High: $108 Avg: $101.5 Low: $95 Last Closed Price: $106.54

LMAT Stock Rating

LeMaitre Vascular stock's rating consensus is Buy, based on 20 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 14 Buy (70.00%), 6 Hold (30.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 20 0 6 14 Strong Sell Sell Hold Buy Strong Buy

LMAT Price Target Upside V Benchmarks

TypeNameUpside
StockLeMaitre Vascular-4.73%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks25.69%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$101.50
Last Closing Price$106.54$106.54$106.54
Upside/Downside---4.73%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26244--10
Feb, 26245--11
Jan, 26245--11
Dec, 25245--11
Nov, 25235--10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 10, 2025Ross OsbornCantor Fitzgerald$95.00$86.969.25%-10.83%
Nov 05, 2025Roth Capital$108.00$87.2623.77%1.37%
Feb 28, 2025Lake Street$110.00$91.8519.76%3.25%
Oct 15, 2024Ross OsbornCantor Fitzgerald$96.00$92.144.19%-9.89%
Aug 20, 2024Daniel StauderJMP Securities$100.00$85.5316.92%-6.14%
Apr 26, 2024Rick WiseStifel Nicolaus$75.00$65.4614.57%-29.60%
Sep 06, 2023Suraj KaliaOppenheimer$70.00$56.7123.44%-34.30%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 10, 2025Cantor FitzgeraldNeutralNeutralhold
Aug 26, 2025Roth CapitalBuyBuyhold
Feb 28, 2025Lake StreetBuyBuyhold
Nov 01, 2024OppenheimerOutperformOutperformhold
Oct 15, 2024JMP SecuritiesNeutralNeutralhold
Oct 15, 2024Cantor FitzgeraldNeutralinitialise
Aug 20, 2024JMP SecuritiesOutperformOutperformhold
May 03, 2024JMP SecuritiesOutperformOutperformhold
Sep 06, 2023OppenheimerOutperforminitialise

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$1.27$0.94$1.36$1.96$2.55--
Avg Forecast$1.28$0.93$1.32$1.94$2.16$2.38$2.60
High Forecast$1.31$0.95$1.33$1.96$2.27$2.55$2.65
Low Forecast$1.26$0.90$1.30$1.86$2.05$2.30$2.54
Surprise %-0.78%1.08%3.03%1.03%18.06%--

Revenue Forecast

$150M $180M $210M $240M $270M $300M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$154.42M$161.65M$193.48M$219.86M$249.60M--
Avg Forecast$154.61M$161.70M$193.61M$220.03M$240.15M$258.75M$284.96M
High Forecast$157.33M$164.10M$194.27M$220.62M$243.71M$259.01M$290.59M
Low Forecast$152.24M$158.05M$193.45M$219.77M$235.60M$258.49M$276.26M
Surprise %-0.12%-0.03%-0.06%-0.07%3.94%--

Net Income Forecast

$20M $28M $36M $44M $52M $60M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$26.91M$20.64M$30.11M$44.04M$57.73M--
Avg Forecast$26.23M$26.90M$30.11M$42.86M$49.79M$56.17M$58.19M
High Forecast$31.47M$32.28M$36.13M$43.95M$50.82M$57.18M$59.42M
Low Forecast$20.98M$21.52M$24.08M$41.77M$45.91M$51.57M$56.95M
Surprise %2.59%-23.28%-2.74%15.96%--

LMAT Forecast FAQ

Is LeMaitre Vascular stock a buy?

LeMaitre Vascular stock has a consensus rating of Buy, based on 20 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 14 Buy, 6 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that LeMaitre Vascular is a favorable investment for most analysts.

What is LeMaitre Vascular's price target?

LeMaitre Vascular's price target, set by 20 Wall Street analysts, averages $101.5 over the next 12 months. The price target range spans from $95 at the low end to $108 at the high end, suggesting a potential -4.73% change from the previous closing price of $106.54.

How does LeMaitre Vascular stock forecast compare to its benchmarks?

LeMaitre Vascular's stock forecast shows a -4.73% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical instruments & supplies stocks industry (25.69%).

What is the breakdown of analyst ratings for LeMaitre Vascular over the past three months?

  • March 2026: 20.00% Strong Buy, 40.00% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 18.18% Strong Buy, 36.36% Buy, 45.45% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 18.18% Strong Buy, 36.36% Buy, 45.45% Hold, 0% Sell, 0% Strong Sell.

What is LeMaitre Vascular’s EPS forecast?

LeMaitre Vascular's average annual EPS forecast for its fiscal year ending in December 2026 is $2.38, marking a -6.67% decrease from the reported $2.55 in 2025. Estimates for the following years are.

What is LeMaitre Vascular’s revenue forecast?

LeMaitre Vascular's average annual revenue forecast for its fiscal year ending in December 2026 is $258.75M, reflecting a 3.67% increase from the reported $249.6M in 2025. The forecast for.

What is LeMaitre Vascular’s net income forecast?

LeMaitre Vascular's net income forecast for the fiscal year ending in December 2026 stands at $56.17M, representing a -2.70% decrease from the reported $57.73M in 2025. Projections indicate .